Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita Therapeutics that has the potential to prevent and reverse liver fibrosis—a ...

A new blood test may help detect liver cancer earlier in people with chronic liver disease, potentially improving access to ...

Fatty liver disease happens when too much fat builds up in the liver. Metabolic dysfunction-associated steatohepatitis (MASH) is a severe type of fatty liver disease where fat buildup causes liver ...

Cytotheryx, a growing Rochester biotech firm working on treatments for liver disease, recently received $60 million in ...

A groundbreaking international trial has found that semaglutide, a drug best known for treating diabetes and obesity, can also reverse a dangerous liver disease called MASH in nearly two-thirds of ...

More than 30% of people worldwide have metabolic dysfunction–associated steatotic liver disease (MASLD; formerly nonalcoholic fatty liver disease), including 65% of those with type 2 diabetes (T2D) ...

Dr. Anjana Pillai says treatment depends on stage and health, with surgery, transplant, local therapy or systemic drugs to help people live longer. Dr. Anjana Pillai explains, in an interview with ...

Researchers from the Cancer Research UK Scotland Institute in Glasgow have discovered why certain cancer-causing genes ...

Lucknow: Hepatic venous pressure gradient (HVPG), special medical test to gauge pressure inside liver, was performed for the ...

Jan 23 (Reuters) - Bausch Health said on Friday its experimental treatment failed to prevent the first clinically visible symptoms of a neurological condition in patients with a type of liver disease, ...

According to experts, fatty liver has become an epidemic in India. Research suggests that approximately one in three adults ...